Sichtbarkeits-Score
100/100
KI-Erwähnungen
7.3K
KI-Suchvolumen
4.3M
Mit Stand vom 17. Februar 2026 erzielt Eli Lilly (lilly.com) einen KI-Sichtbarkeits-Score von 100 von 100, basierend auf insgesamt 7.3K KI-Erwähnungen über Plattformen wie Google KI-Übersichten und ChatGPT hinweg. Die Marke generiert ein KI-Suchvolumen von 4.3M. Im Bereich des traditionellen SEO verzeichnet Eli Lilly geschätzte 3.0M monatliche organische Besuche mit einem Traffic-Wert von $29.9M. Im Vergleich zu Mitbewerbern aus dem Life-Sciences-Sektor belegt Eli Lilly beim Share of Voice der KI-Erwähnungen Rang #2 von 5.
Eli Lilly and Company is a major American pharmaceutical company known for its diabetes treatments (including Mounjaro and Zepbound GLP-1 receptor agonists), oncology drugs, immunology therapies, and neuroscience pipeline. It is one of the fastest-growing pharma companies by market capitalization.
Eli Lilly verzeichnet insgesamt 7.3K KI-Erwähnungen über 2 erfasste Plattformen hinweg und generiert ein KI-Suchvolumen von 4.3M. Auf Google AI Overview entfällt mit 86 % aller Erwähnungen der größte Anteil. KI-Plattformen verknüpfen Eli Lilly mit 20 Marken-Entitäten, darunter Zepbound, Mounjaro, Eli Lilly and Company.
Beispielhafte Fragen, bei denen KI-Plattformen Eli Lilly in ihren Antworten zitieren.
Zepbound (tirzepatide) is an FDA-approved prescription injectable medication for chronic weight management in adults with obesity or overweight with weight-related conditions, and also for adults with moderate-to-severe obstructive sleep apnea (OSA) . It works by mimicking natural hormones (GLP-1 and GIP) to reduce appetite, increase fullness, and slow stomach emptying, leading to less food intake and significant weight loss, alongside diet and exercise. Administered weekly, Zepbound has shown substantial weight reduction and improved OSA symptoms in clinical trials, but common side effects include nausea, diarrhea, and constipation, with rare serious risks like pancreatitis.12345
How it works
Cymbalta (generic name: duloxetine ) is a prescription medication classified as a serotonin-norepinephrine reuptake inhibitor (SNRI) . It is primarily used to treat mental health conditions like depression and anxiety, as well as chronic pain disorders.1234
Uses
Cymbalta is FDA-approved to treat the following conditions in adults:12
How It Works
Cymbalta works by increasing the levels of serotonin and norepinephrine in the brain and spinal cord. These neurotransmitters are responsible for regulating mood and decreasing pain signals.123
Side Effects
Common side effects of Cymbalta include:123
Serious Warnings:
Dosage
Important Considerations
Disclaimer: This information is for educational purposes only and does not constitute medical advice. Always consult a healthcare professional for diagnosis and treatment.
The most common side effects of Mounjaro are gastrointestinal, including nausea, diarrhea, decreased appetite, vomiting, constipation, indigestion, and stomach pain . Many of these digestive issues are mild to moderate and may diminish after a few weeks as the body adjusts to the medication. Less common but more serious side effects are also possible.
Common side effects
Eli Lilly and Company is an American multinational pharmaceutical company headquartered in Indianapolis, Indiana, that discovers, develops, and markets human pharmaceuticals.The company was founded in 1876 by Colonel Eli Lilly and focuses on therapeutic areas like oncology, diabetes, neuroscience, and immunology.Its products include well-known drugs like Trulicity, Mounjaro, and Verzenio.
Company overview
Therapeutic areas
Key products
Trulicity (dulaglutide) is a once-weekly injectable medication for adults and children (10+) with type 2 diabetes , used with diet and exercise to control blood sugar and reduce major heart problems (heart attack, stroke) in at-risk individuals, working by mimicking the GLP-1 hormone to boost insulin, slow digestion, and decrease appetite.Common side effects include nausea, diarrhea, vomiting, abdominal pain, and appetite decrease, but it carries a boxed warning for potential thyroid C-cell tumors (like MTC) and is contraindicated with a personal/family history of MTC or MEN 2. Patients inject it themselves under the skin, using a prefilled pen, and should monitor for serious signs like severe stomach pain, trouble swallowing, or signs of dehydration.
Uses
How it Works (Mechanism)
Administration
Side Effects & Warnings (Black Box Warning)
Eli Lilly rankt für 176.5K organische Keywords und erzielt geschätzte 3.0M monatliche Besuche mit einem Traffic-Wert von $29.9M. Der organische Traffic ist im erfassten Zeitraum von 5.3M auf 6.8M gewachsen. Zu den am höchsten rankenden Keywords gehören „pharmacy near me“ (Position 81), „pharmacy“ (Position 66), „tirzepatide“ (Position 1).
Organischer Traffic
3.0M
geschätzte monatliche Besuche
Organische Keywords
176.5K
rankende Keywords
Traffic-Wert
$29.9M
geschätzter monatlicher Wert
| Suchbegriff | Platzierung | Suchvolumen |
|---|---|---|
| pharmacy near me | 81 | 2.2M |
| pharmacy | 66 | 1.5M |
| tirzepatide | 1 | 1.0M |
| tirzepatide | 2 | 1.0M |
| manjaro | 30 | 823.0K |
| mounjaro | 1 | 823.0K |
| zepbound | 1 | 823.0K |
| company's | 39 | 550.0K |
| dubai states | 74 | 550.0K |
| script express | 93 | 550.0K |
| covermymeds | 56 | 450.0K |
| duloxetine | 61 | 450.0K |
| duloxetine drugs | 75 | 450.0K |
| fluoxetine | 67 | 450.0K |
| s/a | 77 | 450.0K |
| jardiance | 8 | 368.0K |
| moore julianne | 65 | 368.0K |
| advi careers | 59 | 301.0K |
| brand mark usa | 77 | 301.0K |
| caremark cvs | 89 | 301.0K |
Eli Lilly belegt Platz #2 von 5 Mitbewerbern beim Share of Voice für AI-Erwähnungen und erzielt 18 % aller Erwähnungen. Pfizer führt mit 24.2K AI-Erwähnungen. Zu den erfassten Mitbewerbern gehören Pfizer, Merck & Co., AbbVie, Novo Nordisk.
| Unternehmen | Erwähnungen | AI-Volumen |
|---|---|---|
| lilly.com (Sie) | 6.2K | 4.3M |
| novonordisk.com (Novo Nordisk) | 475 | 268.5K |
| pfizer.com (Pfizer) | 24.2K | 18.7M |
| merck.com (Merck & Co.) | 2.3K | 1.4M |
| abbvie.com (AbbVie) | 1.4K | 533.0K |
Dies ist eine statische Momentaufnahme. Das fortlaufende KI-Sichtbarkeits-Monitoring, das Mitbewerber-Benchmarking und die quellengestützten GEO-Inhalte, die Ihren Zitationsfußabdruck verbessern, sind im schlüsselfertigen Wachstumsmotor von VayoMed enthalten.